Interactions of Desmethoxyyangonin, a Secondary Metabolite from Renealmia alpinia, with Human Monoamine Oxidase-A and Oxidase-B.

Interactions of Desmethoxyyangonin, a Secondary Metabolite from Renealmia alpinia, with Human Monoamine Oxidase-A and Oxidase-B.
复制标题

DOI:
10.1155/2017/4018724
复制
发表时间:
2017
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
通讯作者:
Tekwani BL
Tekwani BL
中科院分区:
其他
文献类型:
--
作者:
Chaurasiya ND;León F;Ding Y;Gómez-Betancur I;Benjumea D;Walker LA;Cutler SJ;Tekwani BL

文献摘要

参考文献

被引文献

相似文献

高良姜是热带雨林的一种药用植物,用于治疗蛇咬伤和其他伤害,也可用作退烧、止痛、止吐、抗溃疡和抗惊厥药物。高良姜叶二氯甲烷提取物对人单胺氧化酶--(MAOS-)A和MAO-B有较强的抑制作用。植物化学研究表明,化合物6对MAO-B的亲和力比MAO-A高约30倍,Ki值分别为31和922 NM。酶抑制动力学分析和平衡-透析解离实验表明,去甲氧基杨柳素6与MAO-A和MAO-B可逆结合。通过分子模拟算法研究了化合物6在MAO-A和MAO-B同工酶活性部位的结合作用,证实了去甲氧基杨柳素6与MAO-B的结合优先于MAO-A。MAO-B的选择性可逆抑制剂,如去甲氧基杨柳素6,可能对治疗神经退行性疾病具有重要的治疗意义,如帕金森氏病和阿尔茨海默病。
Renealmia alpinia (Zingiberaceae), a medicinal plant of tropical rainforests, is used to treat snakebites and other injuries and also as a febrifuge, analgesic, antiemetic, antiulcer, and anticonvulsant. The dichloromethane extract of R. alpinia leaves showed potent inhibition of human monoamine oxidases- (MAOs-) A and B. Phytochemical studies yielded six known compounds, including pinostrobin 1, 4′-methyl ether sakuranetin 2, sakuranetin 3, pinostrobin chalcone 4, yashabushidiol A 5, and desmethoxyyangonin 6. Compound 6 displayed about 30-fold higher affinity for MAO-B than MAO-A, with Ki values of 31 and 922 nM, respectively. Kinetic analysis of inhibition and equilibrium-dialysis dissociation assay of the enzyme-inhibitor complex showed reversible binding of desmethoxyyangonin 6 with MAO-A and MAO-B. The binding interactions of compound 6 in the active site of the MAO-A and MAO-B isoenzymes, investigated through molecular modeling algorithms, confirmed preferential binding of desmethoxyyangonin 6 with MAO-B compared to MAO-A. Selective reversible inhibitors of MAO-B, like desmethoxyyangonin 6, may have important therapeutic significance for the treatment of neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease.
DOI: 10.1371/journal.pone.0077626
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Chou TW;Feng JH;Huang CC;Cheng YW;Chien SC;Wang SY;Shyur LF
通讯作者: Shyur LF
DOI: 10.1007/bf02862108
发表时间: 1996-01-01
期刊: ECONOMIC BOTANY
影响因子: 2.6
作者:
Milliken, W;Albert, B
通讯作者: Albert, B
DOI: 10.1590/1983-084x/13_049
发表时间: 2015-06-01
影响因子: --
作者:
NEGRELLE, R.R.B
通讯作者: NEGRELLE, R.R.B
DOI: 10.1371/journal.pone.0157700
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者:
Chua HC;Christensen ET;Hoestgaard-Jensen K;Hartiadi LY;Ramzan I;Jensen AA;Absalom NL;Chebib M
通讯作者: Chebib M
DOI: 10.1016/j.jep.2015.02.012
发表时间: 2015-05-13
影响因子: 5.4
作者:
Gómez-Betancur I;Cortés N;Benjumea D;Osorio E;León F;Cutler SJ
通讯作者: Cutler SJ